https://pharmashots.com/32770/henlius-receives-nmpa-ind-clearance-for-hlx05-n-biosimilar-erbitux/
Henlius Receives NMPA IND Clearance for HLX05-N (Biosimilar, Erbitux) - PharmaShots
Apr 15, 2026 - HLX05-N gains NMPA IND clearance as a biosimilar for metastatic colorectal cancer, showing high similarity to cetuximab.
receivesnmpaindclearance